Inovio Pharmaceuticals Inc. Stock Falls 9.7%, Underperforms Peers
Dow Jones2026/10/13 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slid 9.7% to $1.00 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,204.38 and Dow Jones Industrial Average falling 0.3% to 51,670.10.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 63.3% below its 52-week high of $2.72, which the company achieved on December 17th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 5.7% to $248.61, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.11% to $28.37.
Trading volume totaled 8.4 million, compared to the 50-day average of 3.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 13, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stock futures fluctuate by $650 billions due to news related to Jensen Huang
Nikkei Average Index gains expand to 2.78%
Surprise! Japan intervened in the forex market three times this summer, selling a record 154 trillion yen in three days
Japan has confirmed that it intervened in the foreign exchange market three times this summer, buying yen to support the exchange rate, corroborating earlier market reports. This included the first joint intervention with the United States to support the yen in nearly thirty years.
UBS CEO warns: A Democratic sweep could slow down AI capacity building, valuation concerns are "very important"
UBS CEO Ermotti stated that the U.S. midterm elections may slow down AI capacity building and that the valuations are questionable; he also warned of persistent inflation and the risk of contagion in the European bond market.
Crypto prices
More
